Navigation Links
Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
Date:9/14/2010

SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced the presentation of new data from its North American and European fidaxomicin Phase 3 clinical trials in patients with Clostridium difficile infection (CDI) at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston.  During an oral presentation, investigator Oliver Cornely, M.D., of the University of Cologne, presented data showing that fidaxomicin was superior to vancomycin in treating a CDI recurrence and in reducing the chance of another relapse.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

CDI recurrence occurs in approximately 25% of patients treated with existing therapies and there is no agreement in the medical community on the optimal treatment for a recurrence.  In the two fidaxomicin Phase 3 trials, a separate stratum was constructed of subjects who had experienced a prior CDI episode and recurred within three months of entering the study.  The 178 subjects with recurrent CDI  were randomized to be treated with either fidaxomicin or vancomycin and 128 of these subjects were subsequently evaluable for recurrence within the study. Following treatment, 35.5% (22/62) of the subjects who received vancomycin experienced another recurrence compared to 19.7% (13/66) among the subjects who received fidaxomicin (p=.045).  This equates to a 45% reduction in repeat CDI recurrence with fidaxomicin.

"The Phase 3 trials previously showed that fidaxomicin is superior to vancomycin in the prevention of recurrence.  The data presented today show that fidaxomicin is
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
2. Optimer Pharmaceuticals to Present at September 2009 Investor Conferences
3. Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
4. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
5. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
6. Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
7. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
8. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
9. Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
10. Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
11. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... of these latent viruses is the Epstein Barr Virus ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... theory, a study found that RA patients have high ... , What is Microcompetition? , Dr. Hanan Polansky discovered ...
(Date:1/15/2014)... Freeslate, Inc ., the ... announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high ... in Mumbai, India, is focused on a wide ... and Active Pharmaceutical Ingredients (APIs) for the developed ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... 1360 Almshouse Road, Warrington, Pa. , Details: ... solely dedicated to finding a cure for hepatitis B ... worldwide, will host its annual Crystal Ball on Friday, ... , Each year, the Crystal Ball attracts hundreds ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and ... in the United States and ... Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of ... at the U.S. Food and Drug Administration (FDA). As the ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced today ... present an update on the company,s business,at the Collins ... 2008 at 9:00 a.m. (Eastern Time) at the Mandarin ... live audio broadcast or the subsequent archived,recording, log on ...
... elevates curiosity and re-stimulates scientific interest through compelling stories at ... available in the midst of a subdued background with simple ... are offered to encourage further inquiry and study. , ... ...
... For 5,000 years the only way to shape metal ... with modern nanotechnology, metalworking involves carving metals with electron ... researchers have developed a method to self-assemble metals into ... than a bacterial cell by guiding metal particles into ...
Cached Biology Technology:Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference 2"Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science. 2"Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science. 3Metals shape up with a little help from friends 2Metals shape up with a little help from friends 3
(Date:4/15/2014)... Zero-emission hydrogen fuel cell systems soon could be powering ... at lower costs and with faster refueling times than ... Laboratories and Hawaii Hydrogen Carriers (HHC). , The goal ... storage system that can refuel at low pressure four ... a battery-powered forklift, giving hydrogen a competitive advantage over ...
(Date:4/14/2014)... of subarctic forest moths in Finnish Lapland suggests that ... on animals and plants because much of the harm ... of 80 moth species and found that 90 percent ... study period, from 1978 to 2009. During that time, ... degrees Fahrenheit, and winter precipitation increased as well. , ...
(Date:4/14/2014)... past three decades have caused small but significant changes ... biologists have found that not only have male coquis ... shorter and higher pitched. , Authored by ... physiology and of ecology and evolutionary biology, and Sebastiaan ... male coqui frogs ( Eleutherodactylus coqui ) in 1983 ...
Breaking Biology News(10 mins):Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2
... The National Library of Medicine, a part of the National ... from the papers of one of the twentieth century’s greatest ... , ,Don't miss Crick's sketch of the DNA ... in Science represents a close collaboration between the National Library ...
... Based on successful animal studies, a novel,vaccine that uses ... a way to treat some human breast cancers, say ... Center. [Ed : Her2/neu is a protein ... study, published in the online journal, Breast Cancer Research,on ...
... the "missing" genes for tRNA in an ancient parasite ... parts of the DNA genome. , The research led ... Biophysics and Biochemistry at Yale focuses on the most ... is a member of a new phylogenetic kingdom in ...
Cached Biology News:Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 2Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 3A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 2A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 3Researchers find missing genes of ancient organism 2
... SpeedVac Model SPD131DDA , Our most chemically ... designed to handle the rigors and solvents of ... digital display, dual independent timers, an automatic bleeder ... vapor pathway. , , Adjustable Vacuum Level ...
...
For absolute protein quantification. 4 peptides in 5 vials x 2 nmol per peptide...
The PxE Thermal Cycler (PxE) is a licensed 96 well PCR machine, developed to provide all fundamental features for value for money thermal cycling....
Biology Products: